The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review - PubMed (original) (raw)
Review
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review
Theresa Hahn et al. Biol Blood Marrow Transplant. 2006 Jan.
Free article
Abstract
Evidence supporting the role of hematopoietic stem cell transplantation (SCT) in the therapy of acute lymphoblastic leukemia in adults (> or =15 years) is presented and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published medical literature and for grading the quality and strength of the evidence, and the strength of the treatment recommendations. Treatment recommendations based on the evidence are presented and were reached unanimously by a panel of acute lymphoblastic leukemia experts. The priority areas of needed future research for adult acute lymphoblastic leukemia are: definition of patients at high risk in first complete remission, beyond Philadelphia chromosome positive; outcomes of SCT in older (>50 years) adults; determination if reduced intensity versus myeloablative conditioning regimens yield an equivalent graft-versus-leukemia effect with reduced toxicity; monitoring of minimal residual disease to achieve disease control before SCT; and the use of cord blood and other alternative sources of stem cells for use in adult SCT recipients.
Similar articles
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy PL Jr. Hahn T, et al. Biol Blood Marrow Transplant. 2005 Nov;11(11):823-61. doi: 10.1016/j.bbmt.2005.08.035. Biol Blood Marrow Transplant. 2005. PMID: 16275588 Review. - The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T. Oliansky DM, et al. Biol Blood Marrow Transplant. 2007 Jan;13(1):1-25. doi: 10.1016/j.bbmt.2006.10.024. Biol Blood Marrow Transplant. 2007. PMID: 17222748 Review. - The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.
Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr. Hahn T, et al. Biol Blood Marrow Transplant. 2003 Jan;9(1):4-37. doi: 10.1053/bbmt.2003.50002. Biol Blood Marrow Transplant. 2003. PMID: 12533739 Review. - The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.
Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL Jr, Hahn T. Oliansky DM, et al. Biol Blood Marrow Transplant. 2008 Feb;14(2):137-80. doi: 10.1016/j.bbmt.2007.11.002. Biol Blood Marrow Transplant. 2008. PMID: 18215777 Review. - The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Oliansky DM, Antin JH, Bennett JM, Deeg HJ, Engelhardt C, Heptinstall KV, de Lima M, Gore SD, Potts RG, Silverman LR, Jones RB, McCarthy PL Jr, Hahn T. Oliansky DM, et al. Biol Blood Marrow Transplant. 2009 Feb;15(2):137-72. doi: 10.1016/j.bbmt.2008.12.003. Biol Blood Marrow Transplant. 2009. PMID: 19167676 Review.
Cited by
- Optimal approach to T-cell ALL.
O'Dwyer KM. O'Dwyer KM. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):197-205. doi: 10.1182/hematology.2022000337C. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485091 Free PMC article. Review. - Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee.
Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ. Sharma A, et al. Transplant Cell Ther. 2021 May;27(5):380-388. doi: 10.1016/j.jtct.2020.12.002. Epub 2021 Jan 28. Transplant Cell Ther. 2021. PMID: 33965174 Free PMC article. - Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee.
Sharma A, Badawy SM, Suelzer EM, Murthy HS, Prasad P, Eissa H, Carpenter PA, Hamadani M, Labopin M, Schoemans H, Tichelli A, Phelan R, Hamilton BK, Buchbinder D, Im A, Hunter R, Brazauskas R, Burns LJ. Sharma A, et al. Bone Marrow Transplant. 2021 Apr;56(4):786-797. doi: 10.1038/s41409-020-01199-1. Epub 2021 Jan 29. Bone Marrow Transplant. 2021. PMID: 33514917 Free PMC article. Review. - CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report.
Wen S, Niu Z, Xing L, Wang Y, Li H, Kuang N, Luo J, Zhang X, Wang F. Wen S, et al. BMC Cancer. 2018 Nov 20;18(1):1143. doi: 10.1186/s12885-018-5037-7. BMC Cancer. 2018. PMID: 30458755 Free PMC article. - Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
Chang MC, Chen YL, Lin HW, Chiang YC, Chang CF, Hsieh SF, Chen CA, Sun WZ, Cheng WF. Chang MC, et al. Mol Ther. 2018 Feb 7;26(2):404-419. doi: 10.1016/j.ymthe.2017.11.011. Epub 2017 Nov 21. Mol Ther. 2018. PMID: 29248428 Free PMC article.